Bluebird Bio CEO defends $1.8 million price for gene therapy — 'It's really thinking about it differently'

Brasil Notícia Notícia

Bluebird Bio CEO defends $1.8 million price for gene therapy — 'It's really thinking about it differently'
Brasil Últimas Notícias,Brasil Manchetes
  • 📰 CNBC
  • ⏱ Reading Time:
  • 46 sec. here
  • 2 min. at publisher
  • 📊 Quality Score:
  • News: 22%
  • Publisher: 72%

Bluebird CEO defends $1.8 million gene therapy price — 'It's really thinking about it differently'

Leschly reasoned that the one-time treatment is a game changer for patients, giving them a "lifelong benefit" while avoiding costly blood transfusions every few weeks for the rest of their lives.

Bluebird said patients will only have to pay $1.8 million if the treatment works. The company proposed a five-year installment plan, with 315,000 euros, or $356,567, paid upfront and additional payments due only if the treatment proves effective. It's a form of value-based pricing, Leschly said. "Neither Novartis' drug nor our drug is anywhere near the most expensive drug in the world. It's really thinking about it differently," Leschly said in an interview on CNBC's "Novartis and Bluebird's approvals mark a new era in medicine where new therapies can cure patients in a single treatment — but at a high price.

In rationalizing the expensive price, Novartis said the one-time treatment costs 50% less than the 10-year cost of current chronic management of the disease. Another current treatment for spinal muscular atrophy for children and adults isRelated Tags

Resumimos esta notícia para que você possa lê-la rapidamente. Se você se interessou pela notícia, pode ler o texto completo aqui. Consulte Mais informação:

CNBC /  🏆 12. in US

Brasil Últimas Notícias, Brasil Manchetes

Similar News:Você também pode ler notícias semelhantes a esta que coletamos de outras fontes de notícias.

Bluebird prices gene therapy at 1.575 million euros over five yearsBluebird prices gene therapy at 1.575 million euros over five yearsBluebird bio Inc on Friday set a price for its gene therapy, Zynteglo, at 1.575 ...
Consulte Mais informação »

How Japan’s Biggest Biotech Is Pioneering New Peptide-Based DrugsHow Japan’s Biggest Biotech Is Pioneering New Peptide-Based DrugsHow Japan’s biggest biotech is pioneering new peptide-based drugs paid JapanGov
Consulte Mais informação »

Bluebird prices gene therapy at 1.575 million euros over five yearsBluebird prices gene therapy at 1.575 million euros over five yearsBluebird bio Inc on Friday set a price for its gene therapy, Zynteglo, at 1.575 ...
Consulte Mais informação »

'It's really bad:' Trump's GOP allies privately cringe at dirt comments'It's really bad:' Trump's GOP allies privately cringe at dirt commentsPresident Donald Trump's allies have been privately critical after he told ABC News he'd consider accepting incriminating information about an opponent from a foreign government without calling the FBI, according to multiple sources.
Consulte Mais informação »

Taylor Swift releases new song and album release date - and it’s sooner than you might think!Taylor Swift releases new song and album release date - and it’s sooner than you might think!Taylor's new album is called Lover - find out the release date
Consulte Mais informação »

Katie Price 'moves back into mucky mansion' - but it's had some big changes madeKatie Price 'moves back into mucky mansion' - but it's had some big changes madeFormer glamour girl Katie Price is believed to have been staying with boyfriend Kris Boyson while her home got cleaned up
Consulte Mais informação »



Render Time: 2025-04-02 18:29:13